You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Genome Biology this week: analysis of gut microbiomes from the Hispanic Community Health Study/Study of Latinos, collection of patient-derived tumor cells from gynecological cancers, and more.
The financing will go toward building out its sales teams in the US and Europe in order to market its multiplexed MDx tests for infectious diseases.
The partners are developing a new lab that will focus on research into protein biomarkers with medical, agricultural, and environmental applications.
The test, which will be developed using the companies' respective technologies, will be marketed by Biolidics following clinical validation.
The firm's diagnostics and genomics group saw a 5 percent year-over-year revenue increase in the fourth quarter.
Using a single-nucleus RNA sequencing strategy, investigators tracked down cell type-specific gene expression and networks in Alzheimer's brains.
Tokyo-based Eisai develops drugs primarily for the neurology and oncology markets, including treatments for Parkinson's disease and breast cancer.
A genome-wide association study links more than 40 genes associated with being left handed, Psychology Today reports.
News items for the week of Nov. 18, 2019.
A large genome-wide association in breast cancer cases and controls from Japan led to common variants linked to disease risk at two new and nine known risk loci.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.